insights_auto
Why is SCNI down 7.38%?
Dive Deeperchevron_right
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.13
arrow_downward
-7.38%(-0.090) 1D
$1.19
arrow_upward
+5.28% (+0.060)todayPre-market
Closed: Oct 7, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.20
High
$1.23
Low
$1.12
Mkt. cap
644.13K
Avg. vol.
2.26M
Volume
1.79K
52-wk high
$16.30
52-wk low
$1.12
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
Open
$1.20
High
$1.23
Low
$1.12
Mkt. cap
644.13K
Avg. vol.
2.26M
Volume
1.79K
52-wk high
$16.30
52-wk low
$1.12
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
The Lufkin Daily News
·
1 hour ago
FILE PHOTO: Traders react to the Fed rate announcement on the floor of the NYSE in New York
Yahoo Finance
·
24 minutes ago
Dell Turned $1,000 Into $11,641 in Five Years as AI Servers Crushed the S&P 500
Barron's
·
6 minutes ago
3 Warning Signs That Earnings Season Won’t Be a Slam Dunk for Markets
Bloomberg.com
·
1 hour ago
AI Bubble Risks Worst S&P 500 Crash Since 2008, Strategist Says
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR